Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Dose-dense

Refine Results

Availability

Search results

  • RSS Feed
(1 - 1 of 1)
Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)